Wednesday, July 8, 2026

pharma · Acne Vulgaris · Plasmodium Falciparum Malaria · ATXI

AVENUE THERAPEUTICS

AVENUE THERAPEUTICS patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Bay Harbor Islands, USA HQ
10 Employees
Public company Type
ATXI · NYSE Ticker
Company details
Status
Public
HQ
Bay Harbor Islands, USA
Employees
10
Programs
4
Drugs
8
Patents
1
Intelligence · Patents

AVENUE THERAPEUTICS patents

1 pharmaceutical patents indexed for AVENUE THERAPEUTICS. 0 expire within 24 months.

AVENUE THERAPEUTICS has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 6723695

    CTL epitopes from EBV

    Expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does AVENUE THERAPEUTICS have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do AVENUE THERAPEUTICS patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.